DANAI LIMMATHUROTSAKUL, M.D.
INTERNAL MEDICINE, GASTROENTEROLOGIST
This website uses cookies 🍪
We use cookies to ensure you get the best online experience. For more details, please see our Privacy and Cookie Policy. Read more.
Radiofrequency Ablation (RFA) is a treatment method for liver cancer, including primary liver cancer and metastatic liver cancer that cannot be surgically removed. This technique utilizes high-frequency radio waves, which are converted into heat energy to destroy cancerous cells in the liver. RFA is most effective for small liver tumors, generally those less than 3 centimeters in diameter and located away from major blood vessels.
Thermal ablation is a suitable treatment for tumors smaller than 5 centimeters, with a reported efficacy rate of 97.2%. The most common thermal ablation techniques include Radiofrequency Ablation (RFA) and Microwave Ablation (MWA), both of which use a specialized needle to generate heat and destroy tumor cells.
RFA involves inserting a thin needle into the liver, positioning it precisely at the tumor site with guidance from CT scans or ultrasound. The Radio Frequency (RF) energy is then transmitted through the needle, generating heat up to 100°C, effectively destroying the tumor while minimizing damage to surrounding healthy liver tissue.
The goal of RFA is to eliminate the tumor, including a 0.5 to 1 cm margin of surrounding liver tissue, to prevent recurrence. The needle acts as a conductor, delivering thermal energy to destroy cancerous cells within approximately one hour.
Blood tests including LFT, Coagulogram, Platelet count, AFP, BUN, and Creatinine.
RFA is a highly effective, minimally invasive treatment for liver cancer, providing a viable alternative to surgery while ensuring a faster recovery and lower risk of complications.
INTERNAL MEDICINE, GASTROENTEROLOGIST